| Title |
Author(s) |
| Practical Strategies for Diagnosing and Treating Depression in Women: Menopausal Transition |
Claudio N. Soares, MD, PhD, FRCPC
|
| Practical Strategies for Diagnosing and Treating Depression in Women: Chronic Depression |
Alan Podawiltz, DO, MS, FAPA |
| Tolerability of Antipsychotics: Recent Controversies and Future Management |
W. Wolfgang Fleischhacker, MD |
| Relapse Prevention in Patients With Schizophrenia |
John M. Kane, MD |
| Identifying and Treating Cognitive Impairments in Elderly Patients |
Steven P. Roose, MD |
| Treating Depressive Mixed States in Bipolar Disorders |
Steven C. Dilsaver, MD, and Franco Benazzi, MD, PhD |
| Diagnosing Depressive Mixed States in Bipolar Disorders |
Steven C. Dilsaver, MD, and Franco Benazzi, MD, PhD |
| What Have We Learned About Bipolar Disorder From STEP-BD and Other Practical Trials? |
Andrew A. Nierenberg, MD |
| Bipolar Disorder and Concurrent Psychiatric and Medical Disorders |
Valentim Gentil, MD, PhD (Chair) |
| Observational, Pragmatic, and Clinical Trials in Bipolar Disorder |
Eduard Vieta, MD, PhD |
| Incorporating Clinical Trial Data Into Bipolar Disorder Management |
Terence A. Ketter, MD (Chair) |
| Introduction to Bipolar Disorder and Comorbid Conditions |
Valentim Gentil, MD, PhD (Chair) |
| Overview of Patient Care Issues and Treatment in Bipolar Spectrum and Bipolar II Disorder |
Joseph R. Calabrese, MD
|
| Practical Lessons From Effectiveness Trials of Care Management and Psychoeducation for Bipolar Disorder |
Gregory E. Simon, MD, MPH |
| The Bipolar Spectrum in Children and Adolescents: Developmental Issues |
Kiki D. Chang, MD |
| Medical Monitoring in Patients With Bipolar Disorder: A Review of Data |
Andrea Fagiolini, MD |
| Defining the Bipolar Spectrum and Treating Bipolar II Disorder |
Eduard Vieta, MD, PhD |
| Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities |
Allan H. Young, MD, PhD |
| The Role of Psychosocial Interventions in Bipolar II Disorder: What Do We Know? |
Holly A. Swartz, MD |
| Medical Monitoring in Patients With Bipolar Disorder: Clinical Recommendations |
Edward S. Friedman, MD |
| Treatment of Agitation in Patients With Schizophrenia |
Stephen R. Marder, MD |
| Sexual Dysfunction in Patients Treated With Atypical Antipsychotics |
Jonathan M. Meyer, MD |
| Effect of Hyperprolactinemia During Development in Children and Adolescents |
Christoph U. Correll, MD |
| Sedation as a Side Effect of the Treatment of Mental Disorders |
John M. Kane, MD |
| Management of Patients With Treatment-Resistant Depression |
Michael E. Thase, MD |
| Treating Movement Disorders and Akathisia as Side Effects of Antipsychotic Pharmacotherapy |
Peter F. Buckley, MD |
| Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics |
David C. Henderson, MD |
| Metabolic Risks and Effects of Atypical Antipsychotic Treatment |
Dan W. Haupt, MD |
| The Diagnostic Dilemmas and Clinical Correlates of Mixed States in Bipolar Disorder |
Mark A. Frye, MD |
| Bipolar Mixed Episodes: Characteristics and Comorbidities |
Joseph F. Goldberg, MD |
| Acute Treatment of Patients With Bipolar Mixed Episodes |
Roger S. McIntyre, MD, FRCPC |
| Understanding the Complexity of Bipolar Mixed Episodes |
Susan L. McElroy, MD (Chair) |
| Introduction to Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy |
Rakesh Jain, MD, MPH (Chair) |
| A Clinician's View of the Data on Bipolar Disorder |
Noel C. Gardner, MD |
| The Importance of Facilitating Adherence in Maintenance Therapy for Bipolar Disorder |
W. Clay Jackson, MD, DipTh |
| What Clinicians Need to Know About Neuroprotective Issues in Bipolar Disorder |
Vladimir Maletic, MD |
| Interventions for Acute Mood Episodes in Patients With Bipolar Disorder |
Steven J. Garlow, MD, PhD |
| Practical Strategies for Assessing and Stabilizing Bipolar Patients in Urgent Situations |
Tracey G. Skale, MD |
| Importance of a Correct Initial Diagnosis and Stabilization to Avoid Social and Economic Consequences |
J. Sloan Manning, MD |
| Impact of Substance Use Disorder on ADHD and Its Treatment |
Timothy E. Wilens, MD |
| The Effect of Stimulant Treatment for ADHD on Later Substance Abuse and the Potential for Medication Misuse, Abuse, and Diversion |
Stephen V. Faraone, PhD |
| Managing ADHD in the Presence of Substance Use Disorder |
Himanshu P. Upadhyaya, MBBS, MS (Chair) |
| Diagnosing ADHD in Adults With Substance Use Disorder: DSM-IV Criteria and Differential Diagnosis |
Frances R. Levin, MD |
| Identifying Metabolic Risks With Antipsychotics and Monitoring and Management Strategies |
John W. Newcomer, MD (Chair), and Michael J. Sernyak, MD |
| Integrating General Health Care in Private Community Psychiatry Practice |
Donald C. Goff, MD |
| Monitoring and Managing Weight Gain in the Mentally Ill |
Rohan Ganguli, MD, and Betty Vreeland, MSN, APRN, NP-C, BC |
| Implementing Evidence-Based Medicine: Lessons From Public Mental Health Settings |
Joseph J. Parks, MD |
| Series Introduction and Cardiovascular Disease in Patients With Schizophrenia |
Charles H. Hennekens, MD, and John W. Newcomer, MD (Chair) |
| Evidence of Switching Antipsychotic Therapy to Improve Metabolic Disturbances |
Peter J. Weiden, MD |
| Challenges and Solutions to Integrating Mental and Physical Health Care |
Benjamin G. Druss, MD, MPH |
| Treating DSM-IV Depression With Atypical Features |
Jonathan W. Stewart, MD |
| Translating the Evidence on Atypical Depression Into Clinical Practice |
Mark Hyman Rapaport, MD |
| Atypical Depression: A Valid Subtype? |
Gordon B. Parker, MD, PhD, DSc |
| A History of the Concept of Atypical Depression |
Jonathan R. T. Davidson, MD |
| New Directions in the Treatment of Atypical Depression |
Michael E. Thase, MD |
| Managing Cognitive Deficits and Functioning in Patients With Schizophrenia |
Philip D. Harvey, PhD |
| Comparing Safety and Tolerability of Antipsychotic Treatment |
John W. Newcomer, MD |
| Effectiveness of Antipsychotic Drugs in Patients With Chronic Schizophrenia: Efficacy, Safety, and Cost Outcomes of CATIE and Other Trials |
Jeffrey A. Lieberman, MD (Chair) |
| Cost-Effectiveness Measures, Methods, and Policy Implications from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) for Schizophrenia |
Robert A. Rosenheck, MD |
| Cognitive and Functional Effects of Atypical Antipsychotic Medications |
Philip D. Harvey, PhD |
| Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder |
David L. Dunner, MD (Chair) et al. |
| The Art and Science of Switching Antipsychotic Medications, Part 2 |
Peter J. Weiden, MD; Tim J. Lambert, BSc, MBBS, FRANZP, PhD; Alexander L. Miller, MD; Peter F. Buckley, MD (Chair) |
| The Art and Science of Switching Antipsychotic Medications, Part 1 |
Allan H. Young, MD; Peter J. Weiden, MD; Peter F. Buckley, MD (Chair) |
| Treating Depression Complicated by Comorbid Medical Illness or Anxiety |
Madhukar H. Trivedi, MD (Chair) et al. |
| General Medical Comorbidities and Pain in Depression |
Wayne J. Katon, MD, and Ella Daly, MRCPsych |
| Long-Term Management Strategies to Achieve Optimal Function in Patients With Bipolar Disorder |
Paul E. Keck, Jr., MD |
| Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder |
Michael F. Green, MD |
| Medical Risk in Patients With Bipolar Disorder and Schizophrenia |
John W. Newcomer, MD |
| The Neurobiology of Cognition in Schizophrenia |
Carol A. Tamminga, MD |
| Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia |
Philip D. Harvey, PhD |
| Initiatives to Promote the Discovery of Drugs to Improve Cognitive Function in Severe Mental Illness |
Stephen R. Marder, MD (Chair) |
| Comorbid Schizophrenia and Substance Abuse |
Alan I. Green, MD |
| Management of Comorbid Bipolar Disorder and Substance Abuse |
E. Sherwood Brown, PhD, MD |
| Adolescent Substance Abuse and Psychiatric Comorbidities |
Deborah Deas, MD, MPH |
| Prevalence and Consequences of Dual Diagnosis |
Peter F. Buckley, MD |
| Psychosocial Intervention for Dual Diagnosis |
Mary F. Brunette, MD |
| Neurobiology and the Natural History of Schizophrenia |
Jeffrey A. Lieberman, MD (Chair) |
| Neuroprotection in Schizophrenia |
L. Fredrik Jarskog, MD |
| Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder? |
Dolores Malaspina, MD |
| Update on Bipolar Disorder and Substance Abuse: Recent Findings and Treatment Strategies |
Michael J. Ostacher, MD, MPH; Introduction: Gary S. Sachs, MD |
| Psychosocial Strategies to Improve Concordance and Adherence in Bipolar Disorder |
Noreen Reilly-Harrington, PhD |
| Relationship Between Physical Symptoms and Depression Treatment Response in Patients With Comorbid Medical Conditions |
David A. Fishbain, MD |
| Identifying, Evaluating, and Monitoring Depression in Patients With Medical Conditions |
Larry Culpepper, MD, MPH |
| Recognition and Treatment of Obsessive-Compulsive Disorder |
Wayne K. Goodman, MD |
| Posttraumatic Stress Disorder: Characteristics and Treatment |
Thomas Mellman, MD |
| Recognition and Treatment of Panic Disorder |
R. Bruce Lydiard, MD, PhD (Chair) |
| Bipolar Disorder: Therapeutic Options |
James W. Jefferson, MD |
| |